CCMG
LLY icon

Clark Capital Management Group’s Eli Lilly LLY Stock Holding History

Clark Capital Management Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$131M Buy
142,217
+2,999
+2% +$3.04M 0.81% 25
2025
Q4 		$150M Buy
139,218
+211
+0.2% +$202K 0.92% 20
2025
Q3 		$106M Buy
139,007
+366
+0.3% +$272K 0.66% 36
2025
Q2 		$108M Buy
138,641
+6,272
+5% +$4.87M 0.75% 29
2025
Q1 		$109M Buy
132,369
+21,128
+19% +$17.6M 0.78% 28
2024
Q4 		$85.9M Sell
111,241
-14,168
-11% -$11.7M 0.6% 44
2024
Q3 		$111M Buy
125,409
+4,651
+4% +$4.18M 0.76% 31
2024
Q2 		$109M Buy
120,758
+4,148
+4% +$3.32M 0.8% 24
2024
Q1 		$90.7M Buy
116,610
+4,696
+4% +$3.34M 0.68% 32
2023
Q4 		$65.2M Sell
111,914
-13,147
-11% -$7.67M 0.53% 44
2023
Q3 		$67.2M Buy
125,061
+357
+0.3% +$184K 0.67% 35
2023
Q2 		$58.5M Buy
124,704
+8,969
+8% +$3.76M 0.52% 42
2023
Q1 		$39.7M Sell
115,735
-16,385
-12% -$5.53M 0.44% 65
2022
Q4 		$48.3M Sell
132,120
-31,361
-19% -$11.1M 0.44% 46
2022
Q3 		$52.9M Buy
163,481
+18,303
+13% +$5.8M 0.69% 25
2022
Q2 		$47.1M Buy
145,178
+23,771
+20% +$7.14M 0.62% 31
2022
Q1 		$34.8M Buy
121,407
+1,560
+1% +$401K 0.39% 71
2021
Q4 		$33.1M Sell
119,847
-60,369
-33% -$15.3M 0.41% 90
2021
Q3 		$41.6M Buy
180,216
+176,711
+5,042% +$43.6M 0.57% 46
2021
Q2 		$804K Sell
3,505
-3,253
-48% -$653K 0.01% 271
2021
Q1 		$1.26M Buy
6,758
+444
+7% +$86.9K 0.02% 250
2020
Q4 		$1.07M Buy
6,314
+17
+0.3% +$2.54K 0.02% 263
2020
Q3 		$932K Sell
6,297
-499
-7% -$77.2K 0.02% 246
2020
Q2 		$1.12M Sell
6,796
-3,736
-35% -$573K 0.02% 221
2020
Q1 		$1.46M Buy
10,532
+1,553
+17% +$213K 0.04% 187
2019
Q4 		$1.18M Buy
8,979
+358
+4% +$41.5K 0.02% 212
2019
Q3 		$964K Buy
8,621
+5,067
+143% +$564K 0.02% 220
2019
Q2 		$394K Buy
3,554
+731
+26% +$86.1K 0.01% 251
2019
Q1 		$366K Sell
2,823
-1,357
-32% -$165K 0.01% 255
2018
Q4 		$484K Buy
4,180
+474
+13% +$52.9K 0.01% 238
2018
Q3 		$398K Hold
3,706
– – 0.01% 243
2018
Q2 		$316K Hold
3,706
– – 0.01% 243
2018
Q1 		$287K Buy
+3,706
New +$298K 0.01% 256
2016
Q1 		– Sell
-85,456
Closed -$7.2M – 341
2015
Q4 		$7.2M Sell
85,456
-73,882
-46% -$6.13M 0.58% 55
2015
Q3 		$13.3M Buy
159,338
+2,005
+1% +$169K 1.19% 9
2015
Q2 		$13.1M Buy
157,333
+4,642
+3% +$354K 1.2% 16
2015
Q1 		$11.1M Buy
152,691
+45,878
+43% +$3.27M 1.01% 20
2014
Q4 		$7.37M Buy
106,813
+4,338
+4% +$293K 0.67% 52
2014
Q3 		$6.65M Buy
+102,475
New +$6.49M 0.58% 48

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Clark Capital Management Group's LLY Position: Q1 2026 in Review

Clark Capital Management Group increased its Eli Lilly (LLY) stake by 2.2% in Q1 2026, buying an estimated $3.04M and bringing the position to 142,217 shares worth $131M. The position accounts for 0.81% of the portfolio, ranked #25.

Clark Capital Management Group first reported a position in LLY in Q3 2014 and has held it in 39 quarters since. The position peaked at $150M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Clark Capital Management Group held 142,217 shares of Eli Lilly worth $131M as of Q1 2026.
  • Clark Capital Management Group bought 2,999 Eli Lilly shares in Q1 2026, an estimated $3.04M.
  • Eli Lilly made up 0.81% of Clark Capital Management Group's portfolio in Q1 2026, its #25 holding.
  • Clark Capital Management Group first reported a position in Eli Lilly in Q3 2014 and has held it in 39 quarters since.
  • Clark Capital Management Group's Eli Lilly position peaked at $150M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Clark Capital Management Group's 13F filing for Q1 2026, filed 15 May 2026.